<p>Johnson & Johnson's newly formed consumer health unit Kenvue has been named in claims that the company's talcum powder can cause cancer, the <em>Financial Times</em> reported on Thursday.</p>.<p>Kenvue has been named in at least seven talc lawsuits filed since the start of April, according to the report, citing regulatory filings and people familiar with the matter.</p>.<p>The news comes as <a href="https://www.deccanherald.com/business/johnson-johnson-to-settle-talc-cancer-claims-for-89-bn-1206792.html" target="_blank">Johnson & Johnson (J&J)</a> said it's seeking up to a $42.95 billion valuation for Kenvue in its initial public offering.</p>.<p>Earlier this month, J&J agreed to pay $8.9 billion to settle tens of thousands of lawsuits alleging that talc in its iconic Baby Powder and other products caused cancer, dwarfing the company's original offer of $2 billion.</p>.<p>J&J has claimed that its talc products are safe and do not cause cancer.</p>.<p>One of the new cases naming Kenvue was filed in Middlesex county, New Jersey, on behalf of a husband and wife who live in Louisiana, FT said. Their lawsuit claims Justin Bergeron contracted mesothelioma as a result of using J&J talc containing asbestos, <em>FT</em> reported.</p>.<p>Lawyers working for talc claimants said it could be the first of many claims filed against Kenvue and other J&J divisions not previously named in lawsuits, the paper added.</p>.<p>J&J did not immediately respond to a Reuters request for comment on the lawsuits.</p>
<p>Johnson & Johnson's newly formed consumer health unit Kenvue has been named in claims that the company's talcum powder can cause cancer, the <em>Financial Times</em> reported on Thursday.</p>.<p>Kenvue has been named in at least seven talc lawsuits filed since the start of April, according to the report, citing regulatory filings and people familiar with the matter.</p>.<p>The news comes as <a href="https://www.deccanherald.com/business/johnson-johnson-to-settle-talc-cancer-claims-for-89-bn-1206792.html" target="_blank">Johnson & Johnson (J&J)</a> said it's seeking up to a $42.95 billion valuation for Kenvue in its initial public offering.</p>.<p>Earlier this month, J&J agreed to pay $8.9 billion to settle tens of thousands of lawsuits alleging that talc in its iconic Baby Powder and other products caused cancer, dwarfing the company's original offer of $2 billion.</p>.<p>J&J has claimed that its talc products are safe and do not cause cancer.</p>.<p>One of the new cases naming Kenvue was filed in Middlesex county, New Jersey, on behalf of a husband and wife who live in Louisiana, FT said. Their lawsuit claims Justin Bergeron contracted mesothelioma as a result of using J&J talc containing asbestos, <em>FT</em> reported.</p>.<p>Lawyers working for talc claimants said it could be the first of many claims filed against Kenvue and other J&J divisions not previously named in lawsuits, the paper added.</p>.<p>J&J did not immediately respond to a Reuters request for comment on the lawsuits.</p>